Is MLSS or RGNT more undervalued in 2026?

CirclFi compares Milestone Scientific, Inc. (MLSS) and Regentis Biomaterials Ltd. (RGNT) using 13 institutional-grade valuation models. MLSS has a Quality of Company score of 5.7/10 while RGNT scores 3.6/10.

Which is a better buy — MLSS or RGNT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do MLSS and RGNT valuations compare?

MLSS at $0.39 and RGNT at $1.85 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

MLSS vs RGNT Valuation Comparison 2026 — Intrinsic Value Analysis

MLSS

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Milestone Scientific, Inc.

Quality

5.7

out of 10

Value Trap

SAFE

Price

$0.39

Last close

Models

11/13

Active

RGNT

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Regentis Biomaterials Ltd.

Quality

3.6

out of 10

Value Trap

—

Price

$1.85

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	MLSS Fair Value	MLSS Upside	RGNT Fair Value	RGNT Upside
Bayesian DCF	Intrinsic	$0.10	-73.1%	$2.06	-19.4%
Earnings Power Value	Intrinsic	$0.17	-48.3%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.07	-80.7%	$0.32	-89.0%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for MLSS vs RGNT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MLSS vs RGNT — Which Stock Is More Undervalued?

MLSS scores higher with a 5.7/10 quality rating vs RGNT's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Milestone Scientific, Inc. (MLSS) and Regentis Biomaterials Ltd. (RGNT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MLSS currently trades at $0.39 with a QOC of 5.7/10, while RGNT trades at $1.85 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).